Genetic risk assessment

BEHAVIORAL2 trials

Sponsors

University of Aarhus, Scripps Translational Science Institute

Conditions

Coronary Artery DiseaseGlaucomaProstate Cancer

Unknown Phase

The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice

Active, not recruitingNCT01739062

University of AarhusProstate Cancer

Start: 2013-02-28End: 2031-10-30Updated: 2023-12-04

Prospective Electronic Polygenic Risk Study - Second Phase

Not yet recruitingNCT05175651

Scripps Translational Science InstituteCoronary Artery Disease, Glaucoma

Start: 2023-06-30End: 2027-01-15Target: 10000Updated: 2022-11-07

Related Papers

The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial

PLoS Medicine2020-02-0711 citations

A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice--the ProCaRis study: study protocol.

2013-03-017 citations